In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Countermeasures to Oncology Trial Failure: 5 Smarter Approaches to Trial Design and Analysis
5 Smarter Approaches to Trial Design and Analysis
Alan Phillips, Vice President, Biostatistics and Jia Ma, Senior Program Manager, Biostatistics, of ICON Clinical Research contribute to this article onCountermeasures to Oncology TrialFailures.
-
CRO Industry Update
Just as drug products have become increasingly complex, regulatory and payer demands have added a myriad of complexities and costs todrug development.
-
Postmarket Surveillance and M&A
Vicki Anastasi discusses how a merger or acquisition can impact your medical device’s post-market surveillance strategy.
-
What Errors Do We Miss in Clinical Trials
Clara Heering, Vice President of Clinical Risk Management, examines the deficits in current risk mitigation approaches and presents a new paradigm for risk management that is aligned with the new ICH GCP guidelines.
-
5 Things to Know About ICH GCP (R2) 2016
The rising risk of errors, particularly those with complex sources that may be difficult to ascertain in large organisations.
-
Relationships Matter
In this article Dr. Martin Lachs explains about ongoing clinical trials in the oncology area.
-
Free-living Physical Activity in COPD Patients
Deriving methodology standards for clinical trials through a review of research studies.
-
Site Landscape
Major trends in drug development will reshape the global investigative site landscape.
-
Go and No Go Decisions – Optimizing Design Strategies
Hear perspectives from ICON’s Uma Arumugam, MD in Applied Clinical Trials on utilizing historical data and employing clinically meaningful outcomes in a clinical trial design.
